These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36738796)

  • 1. Utilization pattern of prophylactic measures for prevention of post-ERCP pancreatitis: a National Survey Study.
    Ashat M; Kandula S; Cote GA; Gromski MA; Fogel EL; Sherman S; Lehman GA; Watkins JL; Bick BL; Easler JJ
    Gastrointest Endosc; 2023 Jun; 97(6):1059-1066.e3. PubMed ID: 36738796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practice patterns of post-ERCP pancreatitis prophylaxis techniques in the United States: a survey of advanced endoscopists.
    Avila P; Holmes I; Kouanda A; Arain M; Dai SC
    Gastrointest Endosc; 2020 Mar; 91(3):568-573.e2. PubMed ID: 31743690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors of post-ERCP pancreatitis in high-risk patients despite prevention with prophylactic pancreatic stents.
    Dubravcsik Z; Hritz I; Szepes A; Madácsy L
    Scand J Gastroenterol; 2020 Jan; 55(1):95-99. PubMed ID: 31852319
    [No Abstract]   [Full Text] [Related]  

  • 4. Moderate and severe postendoscopic retrograde cholangiopancreatography pancreatitis despite prophylactic pancreatic stent placement: the effect of early prophylactic pancreatic stent dislodgement.
    Moffatt DC; Pradermchai K; Avula H; Sherman S; Fogel EL; Lehman GA
    Can J Gastroenterol; 2011 Apr; 25(4):215-9. PubMed ID: 21523263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prophylactic stents in the prevention of pancreatitis following endoscopic retrograde cholangiopancreatography].
    Dubravcsik Z; Hritz I; Szepes A; Madácsy L
    Orv Hetil; 2021 Jan; 162(1):31-38. PubMed ID: 33388737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The number of wire placement in the pancreatic duct and metal biliary stent as risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Shin SH; So H; Cho S; Kim N; Baik GH; Lee SK; Park DH
    J Gastroenterol Hepatol; 2020 Jul; 35(7):1201-1207. PubMed ID: 31830336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-World Practice Patterns in the Era of Rectal Indomethacin for Prophylaxis Against Post-ERCP Pancreatitis in a High-Risk Cohort.
    Smith ZL; Elmunzer BJ; Cooper GS; Chak A
    Am J Gastroenterol; 2020 Jun; 115(6):934-940. PubMed ID: 32496740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
    Dumonceau JM; Andriulli A; Elmunzer BJ; Mariani A; Meister T; Deviere J; Marek T; Baron TH; Hassan C; Testoni PA; Kapral C;
    Endoscopy; 2014 Sep; 46(9):799-815. PubMed ID: 25148137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study.
    Lee TH; Moon JH; Choi HJ; Han SH; Cheon YK; Cho YD; Park SH; Kim SJ
    Gastrointest Endosc; 2012 Sep; 76(3):578-85. PubMed ID: 22771100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic duct guidewire placement for biliary cannulation for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis.
    Tse F; Yuan Y; Bukhari M; Leontiadis GI; Moayyedi P; Barkun A
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD010571. PubMed ID: 27182692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic pancreatic stents: does size matter? A comparison of 4-Fr and 5-Fr stents in reference to post-ERCP pancreatitis and migration rate.
    Pahk A; Rigaux J; Poreddy V; Smith J; Al-Kawas F
    Dig Dis Sci; 2011 Oct; 56(10):3058-64. PubMed ID: 21487771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent guidewire passage into the pancreatic duct is an independent risk factor for postendoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) among high-risk individuals: A post-hoc analysis of a randomized controlled trial data.
    Goenka MK; Akshintala VS; Kamal A; Bhullar FA; Bush N; Kumar V; Chakraborty M; Gurakar M; Lakhtakia S; Talukdar R; Trikudanathan G; Khashab MA; Kalloo AN; Reddy DN; Sinha SK; Singh VK; Kochhar R
    J Dig Dis; 2023; 24(6-7):427-433. PubMed ID: 37505932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of post-ERCP pancreatitis and the protective effect of rectal indomethacin in cases of attempted but unsuccessful prophylactic pancreatic stent placement.
    Choksi NS; Fogel EL; Cote GA; Romagnuolo J; Elta GH; Scheiman JM; Chak A; Mosler P; Higgins PD; Korsnes SJ; Schmidt SE; Sherman S; Lehman GA; Elmunzer BJ;
    Gastrointest Endosc; 2015 Jan; 81(1):150-5. PubMed ID: 25527053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UK wide survey on the prevention of post-ERCP pancreatitis.
    Hanna MS; Portal AJ; Dhanda AD; Przemioslo R
    Frontline Gastroenterol; 2014 Apr; 5(2):103-110. PubMed ID: 24724007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis.
    Dumonceau JM; Andriulli A; Deviere J; Mariani A; Rigaux J; Baron TH; Testoni PA;
    Endoscopy; 2010 Jun; 42(6):503-15. PubMed ID: 20506068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with post-ERCP pancreatitis and the effect of pancreatic duct stenting in a pediatric population.
    Troendle DM; Abraham O; Huang R; Barth BA
    Gastrointest Endosc; 2015; 81(6):1408-16. PubMed ID: 25686874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for Post-ERCP Pancreatitis in High-Risk Patients Receiving Post-procedure Rectal Indomethacin.
    Kang X; Zheng L; Zeng W; Yang S; Sun H; Zhang R; Wang X; Wang B; Tao Q; Yao S; Chen J; Pan Y; Guo X
    J Gastrointest Surg; 2018 Nov; 22(11):1903-1910. PubMed ID: 29980976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter prospective cohort study of adverse events associated with biliary endoscopic retrograde cholangiopancreatography: Incidence of adverse events and preventive measures for post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Fujita K; Yazumi S; Matsumoto H; Asada M; Nebiki H; Matsumoto K; Maruo T; Takenaka M; Tomoda T; Onoyama T; Kurita A; Ueki T; Katayama T; Kawamura T; Kawamoto H;
    Dig Endosc; 2022 Sep; 34(6):1198-1204. PubMed ID: 34963021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
    Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
    World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for post-ERCP pancreatitis in high risk patients who have undergone prophylactic pancreatic duct stenting: a multicenter retrospective study.
    Ito K; Fujita N; Kanno A; Matsubayashi H; Okaniwa S; Nakahara K; Suzuki K; Enohara R;
    Intern Med; 2011; 50(24):2927-32. PubMed ID: 22185981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.